Patents by Inventor Stefanie HONNDORF

Stefanie HONNDORF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11406614
    Abstract: The present invention relates to the enhancement of the efficacy of anticancer agents by a composition comprising an aqueous phase, an oil phase, EPA and DHA for use in the treatment of solid tumors, wherein EPA and DHA are present in an amount of at least 65% based on the total weight of the oil phase wherein the composition comprises EPA and DHA in a weight ratio between 1:2 and 1:4, or wherein the composition comprises EPA and DHA in a weight ratio between 6:1 and 4:1 and wherein the treatment comprises administering the composition and administering at least one anticancer agent.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: August 9, 2022
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Martin Westphal, Edmundo Brito De La Fuente, Crispulo Gallegos-Montes, Silke Baasner, Stefanie Honndorf, Lida Quinchia
  • Publication number: 20200306215
    Abstract: The present invention relates to the enhancement of the efficacy of anticancer agents by a composition comprising an aqueous phase, an oil phase, EPA and DHA for use in the treatment of solid tumors, wherein EPA and DHA are present in an amount of at least 65% based on the total weight of the oil phase wherein the composition comprises EPA and DHA in a weight ratio between 1:2 and 1:4, or wherein the composition comprises EPA and DHA in a weight ratio between 6:1 and 4:1 and wherein the treatment comprises administering the composition and administering at least one anticancer agent.
    Type: Application
    Filed: October 5, 2017
    Publication date: October 1, 2020
    Inventors: Martin Westphal, Edmundo BRITO DE LA FUENTE, Crispulo Gallegos-Montes, Silke Baasner, Stefanie HONNDORF, Lida Quinchia
  • Publication number: 20200022941
    Abstract: The present invention relates to the treatment of liver diseases. In particular, it relates to a composition for use in treating and/or preventing a liver disease in a subject, wherein said composition comprises eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) wherein the ratio of EPA to DHA is at least 2:1.
    Type: Application
    Filed: February 6, 2018
    Publication date: January 23, 2020
    Inventors: Martin Westphal, Silke Baasner, Stefanie HONNDORF, Edmundo BRITO DE LA FUENTE, Crispulo Gallegos-Montes, Lida Quinchia-Bustamante